(Q40577276)

21 September 2017

Adverse reactions following annual ivermectin treatment of onchocerciasis in Nigeria (English)

1 reference

21 September 2017

0 references

0 references

0 references

Wellington A Oyibo

1

0 references

author name string

A F Fagbenro-Beyioku

series ordinal

2

1 reference

21 September 2017

1 June 2003

1 reference

International Journal of Infectious Diseases

21 September 2017

1 reference

21 September 2017

7

1 reference

21 September 2017

2

1 reference

21 September 2017

156-159

1 reference

Controlled clinical trial of oral and topical diethylcarbamazine in treatment of onchocerciasis

21 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2803%2990013-0

7 January 2021

Comparison of ivermectin and diethylcarbamazine in the treatment of onchocerciasis.

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2803%2990013-0

7 January 2021

Side-effects of ivermectin in treatment of onchocerciasis.

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2803%2990013-0

7 January 2021

Adverse events following mass ivermectin therapy for onchocerciasis

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2803%2990013-0

7 January 2021

Adverse reactions to ivermectin treatment for onchocerciasis. Results of a placebo-controlled, double-blind trial in Malawi.

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2803%2990013-0

7 January 2021

Community based distribution of ivermectin in eastern Sudan: acceptability and early post-treatment reactions

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2803%2990013-0

7 January 2021

Ivermectin: reduction in prevalence and infection intensity of Onchocerca volvulus following biannual treatments in five Guatemalan communities

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2803%2990013-0

7 January 2021

Adverse reactions after community treatment of onchocerciasis with ivermectin in Guatemala

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2803%2990013-0

7 January 2021

Community-based treatment with ivermectin.

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2803%2990013-0

7 January 2021

Ivermectin detection in serum of onchocerciasis patients: relationship to adverse reactions.

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2803%2990013-0

7 January 2021

10.1016/S1201-9712(03)90013-0

Identifiers

DOI

1 reference

21 September 2017

1 reference

PubMed ID

12839719